Company Filing History:
4 out of 9 
1 out of 5,309 
1 out of 1,932 
Years Active: 2017-2021
Title: The Innovations of Frederick Wayne Holtsberg
Introduction
Frederick Wayne Holtsberg is a notable inventor based in Taneytown, MD (US). He has made significant contributions to the field of biotherapeutics, particularly in the development of antibodies targeting ebolavirus and filoviruses. With a total of 4 patents to his name, Holtsberg's work is pivotal in advancing medical treatments for viral infections.
Latest Patents
Holtsberg's latest patents include groundbreaking innovations. One of his notable patents is for a broadly neutralizing antibody targeting the ebolavirus glycoprotein internal fusion loop. This patent provides a method for preventing, treating, or managing an ebolavirus infection by administering an effective amount of at least one pan-ebolavirus internal fusion loop antibody. This antibody specifically binds to the epitope on two or more ebolavirus species or strains. Another significant patent involves non-human primate-derived pan-ebola and pan-filovirus monoclonal antibodies directed against envelope glycoproteins. This disclosure presents binding molecules that can bind to orthologous epitopes found on two or more filovirus species or strains.
Career Highlights
Throughout his career, Holtsberg has worked with reputable organizations, including Integrated Biotherapeutics, Inc. and Leland Stanford Junior University. His work in these institutions has allowed him to collaborate with other experts in the field and contribute to significant advancements in biotherapeutics.
Collaborations
Holtsberg has collaborated with notable colleagues, including Mohammad Javad Aman and Rajan Prasad Adhikari. These collaborations have further enriched his research and development efforts in the field of viral therapeutics.
Conclusion
Frederick Wayne Holtsberg's contributions to the field of biotherapeutics are invaluable. His innovative patents and collaborations highlight his commitment to advancing medical science and improving treatment options for viral infections. His work continues to inspire future innovations in the field.